Understanding PIK3CA-Related Overgrowth Spectrum (PROS) and Its Treatment Options

Understanding PIK3CA-Related Overgrowth Spectrum (PROS) and Its Treatment Options The PIK3CA-Related Overgrowth Spectrum, or PROS, is a group of rare genetic disorders characterized by the overgrowth of various tissues in the body. These conditions arise from changes, or mutations, in the PIK3CA gene. This gene plays a crucial role in regulating cell growth and division. When it's altered, it can lead to abnormal and excessive cell proliferation, resulting in enlarged tissues, limbs, or organs. The manifestation of PROS can vary significantly from person to person, affecting different parts of the body and presenting a wide range of symptoms and severity. What is PROS? PROS is not a single disease but rather a spectrum of disorders. The specific symptoms and affected tissues depend on the exact mutation in the PIK3CA gene and when during development the mutation occurs. Common tissues affected include fat, muscle, bone, blood vessels, and even the brain. This variability means that diagnosis and treatment require a highly individualized approach. Symptoms of PROS The symptoms of PROS are diverse and depend on the location and extent of the overgrowth. Some common signs and symptoms may include: Enlargement of limbs (macrodactyly) Overgrowth of soft tissues, such as fat (lipomatosis) or muscle (macromastia) Abnormalities in bone structure Vascular malformations (abnormal blood vessels) Neurological issues, such as seizures or developmental delays, if the brain is affected Pain or discomfort due to the enlarged tissues pressing on nerves or restricting movement Functional limitations affecting mobility or daily activities It's important to note that not everyone with PROS will experience all of these symptoms, and the severity can range from mild to severe. Causes of PROS The sole cause of PROS is a mutation in the PIK3CA gene. This gene is essential for a cellular pathway known as the PI3K/AKT/mTOR pathway, which is critical for cell growth, proliferation, survival, and metabolism. When the PIK3CA gene is mutated, this pathway becomes overactive, leading to uncontrolled cell growth and the characteristic overgrowths seen in PROS. These mutations are typically somatic, meaning they occur after conception and are present only in certain cells of the body, not in every cell. This is why the condition can affect specific parts of the body rather than being generalized. Diagnosis of PROS Diagnosing PROS often involves a combination of clinical evaluation, imaging studies, and genetic testing. Clinical Examination: Doctors will assess the physical signs of overgrowth and inquire about the patient's medical history and any developmental concerns. Imaging Studies: Techniques like MRI (Magnetic Resonance Imaging) or CT (Computed Tomography) scans can help visualize the extent and location of the overgrowth in soft tissues, bones, and organs. Genetic Testing: This is a crucial step in confirming the diagnosis. Genetic testing can identify the specific mutation in the PIK3CA gene. This not only confirms PROS but can also provide insights into the potential severity and treatment options. Because PROS can affect various specialists, a multidisciplinary team approach is often necessary for accurate diagnosis and comprehensive care. Treatment Options for PROS While there is currently no cure for PROS, various treatments aim to manage symptoms, improve function, and enhance quality of life. The treatment plan is highly individualized and depends on the specific manifestations of the condition. Targeted Therapy: Alpelisib (Vijoice) A significant advancement in PROS treatment is the development of targeted therapy. Alpelisib (brand name Vijoice) is a medication that specifically inhibits the overactive PI3K protein caused by the PIK3CA mutation. It works by blocking the signaling pathway that drives abnormal cell growth. Approval and Use: Alpelisib is approved for adults and children aged 2 years and older who have severe complications from PROS. It has also been used under compassionate use programs for individuals with PROS who may not meet the strict criteria for approval but could still benefit. Clinical Studies: Clinical trials have shown that alpelisib can reduce the size of masses and alleviate symptoms associated with PROS. Ongoing studies are exploring its effectiveness in a broader range of patients, including those without severe disease, which may expand access in the future. Previous Use: Before its approval for PROS, alpelisib was used as an anticancer medication for certain types of tumors with PIK3CA alterations. Its effectiveness in PROS was recognized through reviews of clinical data from patients who received it off-label. Symptom Management and Supportive Care In addition to targeted therapy, several other treatment modalities are employed to manage the diverse symptoms of PROS: Medications Various medications may be prescribed to manage specific complications: Anticoagulant Therapy: Blood thinners may be used to prevent blood clots, especially if vascular issues are present. Antibiotics: These are used to treat infections, particularly if lymphoid complications are involved. Other Medications: Specialists may prescribe medications to manage issues like movement problems, decreased muscle tone, or pain. Surgery Surgical interventions can be crucial for addressing physical overgrowths and their functional consequences: Debulking Surgery: This procedure aims to reduce the size of enlarged tissues that impair mobility, cause pain, or affect organ function. It can involve removing excess fatty tissue or masses that compress nerves. Brain Surgery: May be necessary to manage neurological complications such as seizures or to correct structural abnormalities in the brain. Orthopedic Surgery: Used to correct skeletal abnormalities, such as extra digits or bone deformities, that cause pain or functional difficulties. Therapies and Assistive Devices Rehabilitative therapies play a vital role in maximizing function and independence: Physical Therapy: Helps improve strength, mobility,

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.